Xeris Biopharma Holdings Overview
Xeris Biopharma Holdings Target Price
Analysts' 12-month price predictions for XERS.
Share Price
$4.67
Average Target Price
$4.00
14.3% downside
14.3% downside1 analysts in the last 4 months
High: $4 | Low: $4
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-07 | Piper Sandler | $4 | 14.3% downside |  |
| 2024-11-11 | H.C. WainwrightOren Livnat | $6.6 |  41.3% upside | |
| 2024-10-23 | OppenheimerLeland Gershell | $5 | 7.1% upside | |
| 2024-05-10 | Piper SandlerDavid Amsellem | $3 | 35.8% downside | |
| 2022-04-28 | Craig-Hallum | $6.5 | 39.2% upside | |